Lori Eduartez
Family · Hallandale Beach, FLNPI 1578990743
Payments from drug & device makers
Across 94 payments — averaging $18.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$234
- Amgen$196
- Tactile Systems Technology Inc$193
- Heartflow, Inc.$169
- Novo Nordisk$137
- GSK$128
- plus $714 from 19 others
What the payments were for
- Food & beverage$1,771100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 9 | $234 |
| Amgen | 11 | $196 |
| Tactile Systems Technology Inc | 21 | $193 |
| Heartflow, Inc. | 2 | $169 |
| Novo Nordisk | 7 | $137 |
| GSK | 6 | $128 |
| Lilly USA, LLC | 7 | $113 |
| Novartis | 5 | $109 |
| Cvrx, Inc. | 3 | $61 |
| Esperion Therapeutics, Inc. | 2 | $51 |
| Johnson & Johnson | 3 | $50 |
| Exact Sciences | 2 | $45 |
| Cashflow Solutions, LLC | 4 | $45 |
| Medtronic | 1 | $30 |
| Abbott | 1 | $25 |
| Amarin Pharma, Inc. | 1 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| AstraZeneca | 1 | $20 |
| Eisai Inc. | 1 | $19 |
| Cleerly, Inc. | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Irhythm Technologies, Inc. | 1 | $18 |
| AbbVie | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Bardy Diagnostics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FFRct$146
How this compares
$1,771 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 16 | $23,454 |
| Repatha SyringeEvolocumab | 11 | $18,141 |
| Repatha SureclickEvolocumab | 11 | $12,149 |
| Atorvastatin Calcium | 92 | $622 |
| Ezetimibe | 37 | $587 |
| Rosuvastatin Calcium | 18 | $236 |
| Metoprolol Succinate | 28 | $229 |
| Losartan Potassium | 13 | $137 |
| ClopidogrelClopidogrel Bisulfate | 13 | $126 |
| Hydrochlorothiazide | 22 | $103 |
| Amlodipine Besylate | 21 | $77 |
| Metoprolol Tartrate | 17 | $27 |
Paid to pharmacies, not to this prescriber.
Other family in Hallandale Beach
- Ivory ChristenHallandale Beach$112K
- John HuffakerVenice$8M
- Stephanie MompointMiami$4.5M
- Miguel TrujilloMiami Gardens$4.4M
- Itsel Cardenas RamonMiami$1M
- Lewis HarringtonTampa$954K
- Adam StrosbergFort Lauderdale$859K
- Danielle PharesFt Lauderdale$713K
- David RodriguezHialeah$658K
- Donna OrtizOrlando$417K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.